Skip to content
10-Q

Quarterly Report

Talis Biomedical Corporation

0000950170-24-055082

← back to feed
Filed
May 8, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 3, 2024 31.69M sh
Shares Diluted Q1 2024 · Mar 31, 2024 1.82M sh
Shares Diluted restated Q1 2024 · Mar 31, 2023 1.81M sh
Capex Q1 2024 · Mar 31, 2024 $0
Capex Q1 2024 · Mar 31, 2023 $24K
Operating Cash Flow Q1 2024 · Mar 31, 2024 −$6.43M
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$16.47M
Cash And Equivalents Q1 2024 · Mar 31, 2024 $70.34M
Cash And Equivalents Q1 2024 · Dec 31, 2023 $76.73M
Cash And Equivalents Q1 2024 · Mar 31, 2023 $112.96M
Stockholders Equity Q1 2024 · Mar 31, 2024 $56.68M
Stockholders Equity Q1 2024 · Dec 31, 2023 $69.12M
Stockholders Equity Q1 2024 · Mar 31, 2023 $110.12M
Stockholders Equity Q1 2024 · Dec 31, 2022 $126.74M
Current Liabilities Q1 2024 · Mar 31, 2024 $9.47M
Current Liabilities Q1 2024 · Dec 31, 2023 $8.77M
Total Liabilities Q1 2024 · Mar 31, 2024 $25.81M
Total Liabilities Q1 2024 · Dec 31, 2023 $25.56M
Current Assets Q1 2024 · Mar 31, 2024 $71.17M
Current Assets Q1 2024 · Dec 31, 2023 $77.68M
Total Assets Q1 2024 · Mar 31, 2024 $82.49M
Total Assets Q1 2024 · Dec 31, 2023 $94.67M
Eps Diluted Q1 2024 · Mar 31, 2024 −$7.15
Eps Diluted restated Q1 2024 · Mar 31, 2023 −$9.84
Eps Basic Q1 2024 · Mar 31, 2024 −$7.15
Eps Basic restated Q1 2024 · Mar 31, 2023 −$9.84
Sga Expense Q1 2024 · Mar 31, 2024 $11.65M
Sga Expense Q1 2024 · Mar 31, 2023 $6.4M
Rd Expense Q1 2024 · Mar 31, 2024 $2.53M
Rd Expense Q1 2024 · Mar 31, 2023 $13.8M
Net Income Q1 2024 · Mar 31, 2024 −$13.04M
Net Income Q1 2024 · Mar 31, 2023 −$17.83M
Operating Income Q1 2024 · Mar 31, 2024 −$14.12M
Operating Income Q1 2024 · Mar 31, 2023 −$19M
Cost Of Revenue Q1 2024 · Mar 31, 2024 $6K
Cost Of Revenue Q1 2024 · Mar 31, 2023 $20K
Revenue Q1 2024 · Mar 31, 2024 $73K
Revenue Q1 2024 · Mar 31, 2023 $1.22M